GLØ Blend

GLØ Blend contains GHK-Cu, BPC-157, and TB-500 — three synthetic peptide sequences with distinct but complementary research profiles studied together in non-human models examining tissue interface signaling, extracellular matrix dynamics, and regenerative pathway activity. GHK-Cu is a copper-binding tripeptide studied in relation to collagen synthesis signaling, metalloproteinase regulation, and gene expression modulation in tissue remodeling research. BPC-157 is a synthetic pentadecapeptide studied in relation to growth factor receptor signaling, angiogenic pathway activity, and tissue interface repair research. TB-500 is a synthetic Thymosin Beta-4 analogue studied in relation to actin-binding dynamics, cytoskeletal organization, and extracellular matrix signaling behavior. Scientific literature examines these compounds both independently and in combination within tissue remodeling and regenerative signaling research frameworks.

Research applications commonly explored in the literature include:

Copper peptide signaling and metalloproteinase regulation research in non-human tissue interface models

Collagen synthesis pathway activity and extracellular matrix remodeling investigation

Angiogenic signaling and growth factor receptor pathway research in tissue repair frameworks

Actin-binding dynamics and cytoskeletal organization modeling in controlled laboratory settings

Gene expression modulation studies within tissue remodeling and wound-associated signaling research

Multi-peptide combinatorial signaling investigation across complementary tissue interface pathways

The lyophilized vial format preserves compound integrity across all three peptide sequences within a single preparation, allowing researchers to evaluate reconstitution characteristics, blend stability, and handling parameters under controlled laboratory conditions. Each GLØ Blend vial from KÖLD is prepared and filled in the United States under sterile laboratory conditions. All batches are verified by independent third-party laboratories for purity, volume accuracy, and molecular identity of all peptide components.

1. What are GHK-Cu, BPC-157, and TB-500 individually studied for?
   GHK-Cu is a copper-binding tripeptide studied in non-human models in relation to collagen synthesis signaling, metalloproteinase regulation, and gene expression modulation within tissue remodeling research. BPC-157 is studied in relation to angiogenic signaling and growth factor receptor pathway activity. TB-500 is studied in relation to actin-binding dynamics, cytoskeletal organization, and extracellular matrix signaling. Scientific literature examines all three compounds within overlapping tissue interface and regenerative signaling research frameworks.
2. Why are these three compounds studied in combination?
   Scientific literature examines GHK-Cu, BPC-157, and TB-500 together due to their complementary and non-overlapping signaling mechanisms across tissue interface research — copper peptide gene expression modulation, angiogenic growth factor signaling, and actin-mediated cytoskeletal dynamics each target distinct pathway nodes. Multi-peptide study designs allow researchers to investigate whether concurrent engagement of these pathways produces differentiated tissue remodeling signaling outcomes.
3. Why is the GLØ Blend provided in a lyophilized vial format?
   The lyophilized format preserves the integrity of all three peptide sequences within a single preparation, supporting compound stability, extended storage, and controlled handling during research preparation. This format allows researchers to evaluate reconstitution behavior and multi-compound blend stability under consistent laboratory conditions.
4. Is the GLØ Blend approved for any use in humans or animals?
   No. This product is not approved for human or veterinary use. All products sold by KÖLD are strictly for in vitro and non-human laboratory research purposes only.
5. How is purity and quality verified for a three-compound blend?
   Each GLØ Blend vial undergoes independent third-party laboratory testing to confirm molecular identity, purity, and volume accuracy for all three peptide components prior to release. Certificates of Analysis reflect testing results for each compound within the blend.

Before Reconstitution

Store sealed vial in a freezer at -20°C (–4°F)

Keep away from light and humidity

After Reconstitution

Store at 4°C (39°F)

Use within 14 days

Avoid repeated freeze-thaw cycles

This compound is supplied as a lyophilized powder.
Use KÖLD Solution (sterile, lab-grade solvent) if your protocol requires reconstitution.
Reconstitute only when ready to begin your study.
For research use only. Not for human or animal use.
Not intended to diagnose, treat, cure, or prevent any disease.